CeraVe vs Cetaphil Market Insights reveal Amazon reviews, growth trends, and consumer preference showdown to find which skincare brand leads online.
In today's hyper-competitive beauty and skincare market, understanding consumer behavior on major e-commerce platforms is critical. This report by Actowiz Solutions delves into CeraVe vs Cetaphil Market Insights on Amazon, offering a data-driven comparison that reveals how each brand fares in reviews, sales trends, product breadth, and customer loyalty. Through years of scrapes and analysis — 2020 through 2025 — we present a holistic view of market dynamics and emerging consumer preferences. The insights are aimed at helping brand managers, retailers, and analysts make informed decisions about positioning, inventory, and growth strategies.
Our first lens focuses on the overall Amazon performance for both brands — total reviews and inferred popularity over time. The following table shows aggregate review volumes on Amazon India and global Amazon marketplaces from 2020 through 2025:
| Year | CeraVe – Total Reviews (000s) | Cetaphil – Total Reviews (000s) |
|---|---|---|
| 2020 | 48 | 52 |
| 2021 | 72 | 65 |
| 2022 | 105 | 78 |
| 2023 | 143 | 95 |
| 2024 | 190 | 112 |
| 2025 | 245 | 130 |
In 2025, CeraVe amassed approximately 245,000 reviews compared to Cetaphil's 130,000 — a 88% higher review volume. This indicates a sharper growth curve for CeraVe over the period. Our CeraVe vs Cetaphil Market Insights analysis suggests that the difference is not merely due to new product launches, but reflects growing consumer preference and repeated purchases. The consistent year-on-year jump for CeraVe post-2021 signals increasing brand trust and visibility, likely driven by larger inventory, better stock availability, and improved Amazon search ranking.
Focusing specifically on CeraVe, we estimated Amazon sales volume (units sold per year) based on available Amazon bestseller ranks and review-to-sales conversion heuristics. The table below presents conservative estimates of CeraVe units sold annually.
| Year | Estimated Units Sold (thousands) | Estimated Revenue (USD millions) |
|---|---|---|
| 2020 | 220 | 9.4 |
| 2021 | 330 | 14.1 |
| 2022 | 500 | 21.5 |
| 2023 | 700 | 30.1 |
| 2024 | 980 | 42.1 |
| 2025 | 1,260 | 54.0 |
Between 2020 and 2025, CeraVe's units sold grew nearly six-fold, and revenue estimates increased over 470%. The year-over-year increase accelerated after 2021. This surge could be attributed to product diversification (new moisturizers, cleansers), international expansion through Amazon Global, and more aggressive pricing or promotions. These trends, revealed through CeraVe vs Cetaphil Market Insights, point to robust demand elasticity for CeraVe's lineup — a sign of rising customer confidence and repeat usage. For stakeholders, this sales trajectory signals a scalable growth model and opportunity for further market penetration.
This section examines the breadth of SKUs offered by both brands on Amazon over the 2020–2025 period. We scraped Amazon listings for each brand's globally visible SKUs (skin-care items, cleansers, moisturizers, creams) and tracked the count year by year.
| Year | CeraVe – Active SKUs | Cetaphil – Active SKUs |
|---|---|---|
| 2020 | 18 | 22 |
| 2021 | 24 | 23 |
| 2022 | 32 | 25 |
| 2023 | 40 | 26 |
| 2024 | 48 | 27 |
| 2025 | 55 | 27 |
While Cetaphil's SKU count remained almost flat after 2020, CeraVe expanded aggressively — tripling its catalog by 2025. This broadening likely contributed to its higher review and sales numbers, as more product types attract a wider customer base. The analysis under CeraVe vs Cetaphil Market Insights reveals that CeraVe's strategy emphasized expansion into moisturizers, targeted skin-serum variants, and niche dermatology-grade offerings, whereas Cetaphil retained a conservative core lineup. For retailers or distributors, this difference signals that CeraVe may be better positioned to capture diversified skincare segments, while Cetaphil remains focused on its established base.
Understanding customer sentiment is as crucial as measuring sales volume. We aggregated review data and calculated average ratings and proportion of 5-star reviews over time for key bestselling products of both brands.
| Year | CeraVe – Avg Rating | % of 5-star Reviews | Cetaphil – Avg Rating | % of 5-star Reviews |
|---|---|---|---|---|
| 2020 | 4.3 | 54% | 4.4 | 58% |
| 2021 | 4.4 | 56% | 4.4 | 57% |
| 2022 | 4.5 | 60% | 4.3 | 55% |
| 2023 | 4.6 | 62% | 4.3 | 54% |
| 2024 | 4.6 | 65% | 4.2 | 52% |
| 2025 | 4.7 | 68% | 4.2 | 50% |
By 2025, CeraVe's average rating rose to 4.7 with 68% of reviews being 5-star, surpassing Cetaphil's 4.2 average and 50% 5-star ratio. This shift — captured via our CeraVe vs Cetaphil Market Insights — suggests improving product satisfaction and customer loyalty for CeraVe. Additionally, the increasing gap over the years indicates that Cetaphil may not be innovating or addressing customer feedback as effectively. For brand strategists, this signals that product enhancements, packaging improvements, or marketing efforts may be necessary for Cetaphil to regain ground. On the other hand, CeraVe's upward trend could be leveraged in marketing campaigns as proof of consistent quality and customer trust.
To ensure robustness of our findings, we employed automated scraping pipelines with periodic snapshots (once per quarter) for Amazon marketplaces. Across 2020–2025, the volume of data points collected per snapshot increased significantly:
| Year | Total Product-Page Snapshots | Review-Page Snapshots | Price & Stock Snapshots |
|---|---|---|---|
| 2020 | 1,200 | 4,500 | 2,100 |
| 2021 | 1,800 | 6,200 | 3,000 |
| 2022 | 2,500 | 8,000 | 4,200 |
| 2023 | 3,400 | 10,500 | 5,800 |
| 2024 | 4,600 | 14,000 | 7,500 |
| 2025 | 6,200 | 18,300 | 9,400 |
The growth in data volume reflects increasing Amazon activity — more SKUs, more reviews, and more frequent price/stock changes. Our CeraVe vs Cetaphil Market Insights are built on this large-scale, consistent data foundation, which ensures trend validity and minimizes sampling bias. For analytics and forecasting purposes, maintaining such data fidelity is crucial. Our scraping framework also includes deduplication, timestamping, and verification against Amazon's public API where available — ensuring legitimacy and reliability of data used for decision-making.
Combining sales, reviews, and catalog breadth, we project the next phase (2026–2028) for both brands under current conditions. Based on growth CAGR from 2022–2025:
| Brand | Projected Units Sold in 2026 (thousands) | Estimated Market Share (on Amazon) by 2028 |
|---|---|---|
| CeraVe | 1,580 | ~41% |
| Cetaphil | 150 | ~14% |
If trends continue, CeraVe could reach roughly 1.6 million units sold in 2026, and may hold about 41% of the Amazon skincare market by 2028. Cetaphil, in contrast, may see stagnation or minor growth without new SKUs or refreshed marketing — holding around 14%. These projections, part of our CeraVe vs Cetaphil Market Insights, highlight a widening dominance gap. For investors and distributors, this signals that CeraVe is positioned for aggressive expansion, while Cetaphil needs revitalization or innovation. Brands seeking partnerships should consider stocking more CeraVe SKUs or negotiating exclusives to ride this upward momentum.
When you engage Actowiz Solutions, you get not just raw data — but comprehensive, actionable insights generated from large-scale, consistent scraping and deep analytics. Our automated pipelines capture product catalogs, price fluctuations, stock levels, and review sentiment across global Amazon marketplaces. Using these, we synthesize CeraVe vs Cetaphil Market Insights that help you understand competitive positioning, growth opportunities, and potential threats. Our team delivers cleaned, structured datasets, dashboards, and forecast models — enabling you to make data-backed strategic decisions, optimize inventory, and plan marketing or distribution moves ahead of time.
Our analysis clearly shows CeraVe gaining strong momentum on Amazon — outpacing Cetaphil across reviews, sales volume, product breadth, and customer satisfaction. Through robust Web Crawling service and advanced Web Data Mining, Actowiz Solutions has distilled these trends into actionable intelligence under the banner of CeraVe vs Cetaphil Market Insights.
Our web scraping expertise is relied on by 4,000+ global enterprises including Zomato, Tata Consumer, Subway, and Expedia — helping them turn web data into growth.
Watch how businesses like yours are using Actowiz data to drive growth.
From Zomato to Expedia — see why global leaders trust us with their data.
Backed by automation, data volume, and enterprise-grade scale — we help businesses from startups to Fortune 500s extract competitive insights across the USA, UK, UAE, and beyond.
We partner with agencies, system integrators, and technology platforms to deliver end-to-end solutions across the retail and digital shelf ecosystem.
Complete guide to scraping Shopify store data in 2026. Extract product prices, reviews, and inventory from Shopify stores for competitive intelligence.
Discover how Natural Grocers achieved a 23% increase in promotional ROI using real-time organic product pricing intelligence. Learn how data-driven pricing strategies enhance promotions and retail performance.
Track UK Grocery Products Daily Using Automated Data Scraping across Morrisons, Asda, Tesco, Sainsbury’s, Iceland, Co-op, Waitrose, and Ocado for insights.
Whether you're a startup or a Fortune 500 — we have the right plan for your data needs.